Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

The quest for dosage and combination optimisation in early drug development

Role of pharmacogenomics, pharmacokinetics, and pharmacodynamics for dose optimisation in oncology drug development

Date

28 Feb 2024

Session

The quest for dosage and combination optimisation in early drug development

Topics

Genetic and Genomic Testing

Tumour Site

Presenters

George P. Patrinos

Authors

G.P. Patrinos

Author affiliations

  • Department Of Pharmacy, University of Patras, 265 04 - Patras/GR

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.